Pharma & Biotech

Within the fast-paced biotechnology landscape, Denali Therapeutics continues to command investor attention. The company's trajectory is being shaped by a...

Facing the impending loss of patent protection for its key immunology drug Stelara, Johnson & Johnson is strategically bolstering its...

The investment case for Swiss pharmaceutical giant Roche presents a complex picture, marked by promising clinical developments in one area...

FutureGen Industries is shifting its investment approach in response to evolving liquidity conditions within the technology sector. Having realized gains...

Investors are preparing to scrutinize BioNTech's upcoming annual report, viewing it as far more than a routine financial disclosure. The...

Moderna Inc. has resolved a multi-year legal dispute concerning its foundational mRNA technology, removing a significant overhang that has weighed...

Investor attention is firmly fixed on Sangamo Therapeutics as the company approaches several pivotal near-term events. The dual catalysts of...

The biopharmaceutical company Outlook Therapeutics is approaching a pivotal transition, moving from clinical development into the commercial phase. This shift...

This week, Viking Therapeutics' management is engaging directly with institutional investors at two separate events in Miami. The central topic...

Amid a dynamic biotechnology landscape, clinical-stage companies are drawing increased investor attention. Lobe Sciences operates within a sector currently characterized...